Why does chronic bronchitis and lung infection accelerate lung function decline Source: Research Seminar 2021 – Lung function trajectories from birth to death, health and disease, and pre-war to today Year: 2021
Distinct clinical phenotypes of airways disease defined by cluster analysis Source: Eur Respir J 2009; 34: 812-818 Year: 2009
The role of respiratory viruses in etiological structure of exacerbation of chronic and recurrent lung diseases in children Source: Eur Respir J 2007; 30: Suppl. 51, 391s Year: 2007
Analysis of parameters of lung function in patients with severe chronic obstructive pulmonary disease Source: Eur Respir J 2001; 18: Suppl. 33, 214s Year: 2001
Linking clinical phenotypes of chronic lung allograft dysfunction to changes in lung structure Source: Eur Respir J 2015; 46: 1430-1439 Year: 2015
Characterization of COPD phenotype: comparison of the perceptual response to exercise in emphysema and chronic bronchitis patients Source: Annual Congress 2008 - Respiratory muscles in disease Year: 2008
Variability and effects of bronchial colonization on symptoms and lung function in moderate COPD Source: Annual Congress 2006 - Clinical aspects and treatment of lower respiratory infection in COPD patients Year: 2006
The association between serum osmolality and lung function among adults Source: Eur Respir J 2008; 32: 98-104 Year: 2008
Impact of a single chronic obstructive pulmonary disease (COPD) exacerbation on lung function decline: Analysis of UPLIFT® Source: Annual Congress 2012 - Exacerbations of asthma and COPD: assessment, impact and novel treatments Year: 2012
A level of an alpha-1-proteinihibitor in patients with chronic bronchitis and lung tuberculosis Source: Eur Respir J 2003; 22: Suppl. 45, 339s Year: 2003
Chronic bronchitis: a risk factor for bronchial infection Source: Eur Respir Monogr 2013; 60: 18-26 Year: 2013
Defining the contribution of emphysema and chronic bronchitis in COPD patients Source: Eur Respir J 2003; 22: Suppl. 45, 539s Year: 2003
Overlapping biologic exacerbation clusters in asthma and chronic obstructive pulmonary disease have distinct sputum mediator and microbiome profiles Source: International Congress 2018 – Biomarkers of COPD and asthma-COPD overlap syndrome (ACOS) Year: 2018
Prognosis: what is the contribution of inflammation to the decline in lung function in airway disease? Source: Annual Congress 2007 - Inflammatory phenotypes in airway disease Year: 2007
Chronic bronchitis and plasma markers of inflammation predict incidence of COPD Source: Eur Respir J 2007; 30: Suppl. 51, 681s Year: 2007
Patterns of lung function abnormalities in smokers as possible manifestation of "early" COPD phenotypes Source: Annual Congress 2012 - New issues in pulmonary function Year: 2012
Phenotypic markers of asthma and COPD at the tissue level Source: Annual Congress 2005 - Inflammatory phenotypes of asthma and COPD: the end of traditional diagnosis, or not? Year: 2005
Chronic bronchitis, COPD and lung function in Norwegian farmers: the role of biological agents Source: Eur Respir J 2006; 28: Suppl. 50, 146s Year: 2006
Surfactant protein B polymorphisms, pulmonary function and COPD in 10,231 individuals Source: Eur Respir J 2011; 37: 791-799 Year: 2011